Rubicon Research is a specialty pharmaceutical company focused on developing high quality products using innovative technologies for the global market. We are committed to designing effective value-added formulations that enrich lives around the world.
Rubicon Research has several commercial products in the U.S. market with a rich pipeline of over 70 products in development or under review. We leverage our proprietary technologies and specialized formulation development skills, along with optimization of various pharmacokinetic parameters to provide solutions to complex delivery challenges.
Read MoreStarted as India’s first independent product development company, Rubicon Research has developed and scaled up several drug products. In 2016, we successfully scaled up our 100th product and have gone on to expand our development expertise with a commercial focus, leading to multiple product approvals and launches.
Read MoreApproved products in the US
SKUs launched in US
Billion extended units sold in the US (2023)
Products in the pipeline
Patents in drug delivery technologies
Proprietary drug delivery technologies
Rubicon Research understands and satisfies your need for world-class expertise and resources for developing elegant and robust products.
Read MoreRubicon Research has built and expanded on strong strategic partnerships primarily in development, manufacturing, and regulatory support of pharmaceutical products.
Read More